Gadoxetate Disodium-Enhanced Imaging of Gradenigo Syndrome in End-Stage Renal Disease

Keyphrases

• End-stage Renal Disease 100%
• Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid (Gd-EOB-DTPA) 100%
• Enhanced Imaging 100%
• Gradenigo's Syndrome 100%
• Brain MRI 66%
• Mastitis 66%
• Nephrogenic Systemic Fibrosis 66%
• Gadoxetate 66%
• Right-sided 33%
• Older Men 33%
• Binocular 33%
• Headache 33%
• New Onset 33%
• IV Antibiotics 33%
• Unique Properties 33%
• Radiology 33%
• Renal Disease 33%
• Trigeminal Nerve 33%
• Diagnostic Challenge 33%
• Medical History 33%
• Clinical Suspicion 33%
• Gadolinium-based Contrast Agents 33%
• Patient History 33%
• Polymicrobial 33%
• Peritoneal Dialysis 33%
• Failure to Thrive 33%
• Postsurgical Changes 33%
• Double Vision 33%
• Non-enhancing 33%
• Abducens Nerve 33%
• Tympanomastoidectomy 33%
• Intracranial Empyema 33%
• Hepatobiliary Excretion 33%

Medicine and Dentistry

• End Stage Renal Disease 100%
• Gradenigo's Syndrome 100%
• Gadoxetic Acid 100%
• Magnetic Resonance Imaging of Brain 66%
• Mastoiditis 66%
• Nephrogenic Systemic Fibrosis 66%
• Magnetic Resonance Imaging 33%
• Infection 33%
• Contrast Medium 33%
• Nephropathy 33%
• Radiology 33%
• Medical History 33%
• Headache 33%
• Failure to Thrive 33%
• Peritoneal Dialysis 33%
• Trigeminal Nerve 33%
• Diplopia 33%
• Abducens Nerve 33%
• Empyema 33%
• Antibiotics 33%
• Gadolinium 33%